Participation within Inner Circle is based on sales achievements that rank Alithya in the top echelon of Microsoft's AI Business Solutions global network of partners. It's widely acknowledged that ...

Ultralytics Inc., a developer of computer vision models, today announced that it has raised $30 million in funding. Elephant ...

Discover high-paying remote jobs starting at $55 per hour. These roles let you work from anywhere and are perfect even if you ...

UiPath is showing accelerating revenue growth, improved margins, and raised guidance, signaling strong adoption of its agentic AI products. The company's ARR base at $1.72 billion already exceeds Wall ...

UiPath, Inc. PATH shares are trading higher Friday after the company reported second quarter results above estimates and raised its fiscal year 2026 sales guidance. What To Know: The company reported ...

UiPath Inc. raised its full-year revenue outlook after cruising past Wall Street’s expectations and swinging to a profit in its latest quarterly results, powered by momentum in its artificial ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $12.88, with a high estimate of $15.00 and a low estimate of $12.00. Experiencing a 11.9% ...

Daniel Dines, Co-Founder, CEO, & Executive Chairman of the Board, opened by crediting improved execution and platform innovation for shaping the company's strong financial results, highlighting that ...

In the wake of Anthropic’s $1.5 billion copyright settlement, the AI industry is coming to terms with its training data problem. There are as many as 40 other pending cases that seek damages for ...

The stock market fumbled an early gain on Friday as Wall Street weighed rising rate-cut odds against worries about the economy. The Dow Jones Industrial Average fell 220 points, or 0.5%. The S&P 500 ...

The Centre has unveiled draft rules for licensing of core telecom services under the Telecommunications Act, 2023, marking a major step in overhauling the regulatory framework for India’s ...

Sept 3 (Reuters) - Swiss drugmaker Novartis (NOVN.S), opens new tab has signed an up to $5.2 billion licensing and options deal with Argo Biopharmaceutical for its experimental candidates that target ...